Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Sunshine Biopharma (SBFM) over the last 14 years, with Q3 2025 value amounting to -$9.3 million.

  • Sunshine Biopharma's Enterprise Value rose 2375.93% to -$9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.3 million, marking a year-over-year increase of 2375.93%. This contributed to the annual value of -$9.7 million for FY2024, which is 4054.55% up from last year.
  • According to the latest figures from Q3 2025, Sunshine Biopharma's Enterprise Value is -$9.3 million, which was up 2375.93% from -$10.3 million recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Enterprise Value ranged from a high of -$1.7 million in Q2 2021 and a low of -$41.7 million during Q2 2022
  • Moreover, its 5-year median value for Enterprise Value was -$12.2 million (2024), whereas its average is -$14.6 million.
  • Per our database at Business Quant, Sunshine Biopharma's Enterprise Value plummeted by 970642.46% in 2021 and then soared by 5353.92% in 2023.
  • Over the past 5 years, Sunshine Biopharma's Enterprise Value (Quarter) stood at -$2.1 million in 2021, then plummeted by 963.27% to -$21.8 million in 2022, then grew by 25.35% to -$16.3 million in 2023, then surged by 40.55% to -$9.7 million in 2024, then grew by 3.92% to -$9.3 million in 2025.
  • Its last three reported values are -$9.3 million in Q3 2025, -$10.3 million for Q2 2025, and -$8.2 million during Q1 2025.